Levetiracetam for Treatment of Pain Associated With Fibromyalgia
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of levetiracetam in
reducing the pain of fibromyalgia when compared to placebo. Levetiracetam, an anti-seizure
drug, is currently FDA-approved and marketed for use in patients with seizures. Levetiracetam
may relieve pain by reducing abnormal activity in the nervous system. A placebo is an
inactive substance.